Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia

March 2000

The FDA just approved Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia.

This is the first antibiotic to be approved for this use.

Strep pneumoniae is the most common cause of community-acquired pneumonia. It used to be very sensitive to penicillin...but now resistance is growing.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

whether hormone replacement therapy increases the risk of breast cancer
Gastroenterology Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS)
Pediatrics Augmentin is more effective than Zithromax for otitis media
Pediatrics The first oral solution that contains ONLY trimethoprim
Immunizations new 2-dose regimen for giving Recombivax HB (hepatitis B vaccine) to ADOLESCENTS
Immunizations more widespread use of varicella vaccine (Varivax)
Cardiology whether vitamin E reduces the risk of heart disease
Women's Health Ortho-Prefest, a new combo HRT regimen for postmenopausal women
Women's Health metformin for Polycystic Ovary Syndrome (PCOS)
Ophthalmology three new eye drops for itching due to allergic conjunctivitis
Infectious Diseases Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia
Infectious Diseases Sporanox (itraconazole) now comes in IV form
which calcium supplement to recommend for a particular patient
Antiepileptics two new anti-epileptics
drug interactions with St. John's wort

Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents